Literature DB >> 81494

Enhancement of anaphylactic mediator release from guinea-pig perfused lungs by fatty acid hydroperoxides.

J J Adcock, L G Garland, S Moncada, J A Salmon.   

Abstract

Fragments of chopped lung from indomethacin treated guinea-pigs had an anti-aggregating effect when added to human platelet rich plasma (PRP), probably due to the production of prostacyclin (PGI2) since the effect was inhibited by 15-hydroperoxy arachidonic acid (15-HPAA, 10 micrograms ml(-1)). Both 15-HPAA (1-20 micrograms ml(-1) min (-1)) and 13-hydroperoxy linoleic acid (13-HPLA, 20 micrograms ml(-1) min(-1)) caused a marked enhancement of the anaphylactic release of histamine, slow-reacting substance of anaphylaxis (SRS-A) and rabbit aorta contracting substance (RCS) from guinea-pig isolated perfused lungs. This enhancement was not reversed by the concomitant infusion of either PGI2 (5 micrograms ml(-1) min (-1)) or 6-oxo-prostaglandin F1alpha (6-oxo-PGF1alpha, 5 micrograms ml(-1) min(-1)). Anaphylactic release of histamine and SRS-A from guinea-pig perfused lungs was not inhibited by PGI2 (10 ng - 10 microgram ml(-1) min(-1)) but was inhibited by PGE2 (5 and 10 micrograms ml(-1) min (-1)). Antiserum raised to 5,6-dihydro prostacyclin (PGI1) in rabbits, which also binds PGI2, had no effect on the release of anaphylactic mediators. The fatty acid hydroperoxides may enhance mediator release either indirectly by augmenting thromboxane production or by a direct effect on sensitized cells. Further experiments to distinguish between these alternatives are described in the accompanying paper (27).

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 81494     DOI: 10.1016/0090-6980(78)90019-9

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  14 in total

Review 1.  Pharmacological studies of pulmonary anaphylaxis in vitro: a review.

Authors:  P O Ogunbiyi; P Eyre
Journal:  Agents Actions       Date:  1985-12

2.  15-Hydroxy-5,8,11,13-eicosatetraenoic acid inhibits human vascular cyclooxygenase. Potential role in diabetic vascular disease.

Authors:  B N Setty; M J Stuart
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

3.  A possible role for lipoxygenase products as regulators of airway smooth muscle reactivity.

Authors:  J J Adcock; L G Garland
Journal:  Br J Pharmacol       Date:  1980-06       Impact factor: 8.739

4.  Effects of exogenous prostaglandins on the release of leukotriene C4-like immunoreactivity and on coronary flow in indomethacin-treated anaphylactic guinea-pig hearts.

Authors:  U Aehringhaus; A Dembinska-Kiéc; B A Peskar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-07       Impact factor: 3.000

5.  Stimulation of leukotriene biosynthesis in human blood leukocytes by platelet-derived 12-hydroperoxy-icosatetraenoic acid.

Authors:  J Maclouf; B F de Laclos; P Borgeat
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

6.  Release of 15-hydroxy-5,8,11,13-eicosatetraenoic acid and cysteinyl-leukotrienes in carrageenin-induced inflammation: effect of non-steroidal anti-inflammatory drugs.

Authors:  B M Peskar; M Trautmann; P Nowak; B A Peskar
Journal:  Agents Actions       Date:  1991-07

Review 7.  Nimesulide in the treatment of chronic bronchitis.

Authors:  M Sofia; A Molino; M Mormile; A Stanziola; I Scaricabarozzi; L Carratù
Journal:  Drugs       Date:  1993       Impact factor: 9.546

8.  Arachidonate metabolism via lipoxygenase and 12L-hydroperoxy-5,8,10,14-icosatetraenoic acid peroxidase sensitive to anti-inflammatory drugs.

Authors:  M I Siegel; R T McConnell; N A Porter; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

9.  13-Hydroperoxylinoleic acid inhibits rat liver glyoxalase II.

Authors:  E Gillespie
Journal:  Inflammation       Date:  1981-09       Impact factor: 4.092

10.  Antiinflammatory effects of free radical scavengers and antioxidants: further support for proinflammatory roles of endogenous hydrogen peroxide and lipid peroxides.

Authors:  P C Bragt; J I Bansberg; I L Bonta
Journal:  Inflammation       Date:  1980-09       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.